VU0285655-1
VU0285655-1 (BML-280) is a potent, selective phospholipase D2 (PLD2) inhibitor used in diabetic retinopathy research. It has been shown in vitro to inhibit high glucose-induced caspase-3 activation and loss of cell viability, supporting its application in studying metabolic disease-related cellular pathways.
Product Specifications
CAS Number
1158347-73-9
Product Name Alternative
BML280, BML-280, BML 280, Interleukin Related, PLD2, TNF, VU-0285655, VU0285655-1, VU 0285655
Field of Research
Cell Biology, Immunology & Inflammation, Metabolism Research
Purity
98.57% (May vary between batches)
Solubility
DMSO:50 mg/mL (116.41 mM)
Smiles
O=C1C2 (N (CN1) C3=CC=CC=C3) CCN (CCNC (=O) C4=CC5=C (N=C4) C=CC=C5) CC2
Molecular Formula
C25H27N5O2
Molecular Weight
429.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PROTP01009-1-500ug 500 µg
Human recombinant Serpin A1/alpha 1-Antitrypsin protein
Sign In for Pricing
View Details 217344-AP 100 µL
ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) (AP) discontinued
Sign In for Pricing
View Details